112 related articles for article (PubMed ID: 36100916)
1. SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose.
Zhang X; Si G; Lu H; Zhang W; Zheng S; Huang Z; Liu L; Xue Y; Zheng G
Virol J; 2022 Sep; 19(1):148. PubMed ID: 36100916
[TBL] [Abstract][Full Text] [Related]
2. Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection.
Tong X; Huang Z; Zhang X; Si G; Lu H; Zhang W; Xue Y; Xie W
Infect Drug Resist; 2022; 15():5567-5573. PubMed ID: 36172623
[TBL] [Abstract][Full Text] [Related]
3. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.
He S; Fang Y; Yang J; Wang W
Front Public Health; 2022; 10():1032957. PubMed ID: 36620263
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
Torres I; Giménez E; Albert E; Zulaica J; Álvarez-Rodríguez B; Burgos JS; Peiró S; Limón R; Vanaclocha H; Rodado C; Botija P; Sifre A; Tur B; Lozano RA; Orosa I; Vicente-Ruiz M; Carrión RJ; Clari MÁ; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Geller R; Navarro D;
J Med Virol; 2022 Sep; 94(9):4216-4223. PubMed ID: 35585782
[TBL] [Abstract][Full Text] [Related]
5. Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection.
Zhu Z; Cai J; Tang Q; Mo YY; Deng T; Zhang X; Xu K; Wu B; Tang H; Zhang Z
BMC Pulm Med; 2023 May; 23(1):177. PubMed ID: 37217986
[TBL] [Abstract][Full Text] [Related]
6. Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China.
Yang P; Dang B; Kang W; Li X; Wang T; Li R; Peng M; Liu Y; Wang L; Cheng Y; Yu S; Wei M; Gao H; Kang W; Shang L
Front Public Health; 2023; 11():1107343. PubMed ID: 36960364
[TBL] [Abstract][Full Text] [Related]
7. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
8. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B
J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective observation and analysis of autoimmune-related indicators in 317 patients with acute Omicron variant infection].
Guo X; Luo X; Wu B; Wang W; Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):581-585. PubMed ID: 35924511
[TBL] [Abstract][Full Text] [Related]
10. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
[TBL] [Abstract][Full Text] [Related]
11. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Cocco E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Pizzorno M; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
EBioMedicine; 2022 Jun; 80():104042. PubMed ID: 35526306
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with negative conversion of viral RNA in hospitalized children infected with SARS-CoV-2 Omicron variant in Shanghai, China: a retrospective analysis.
Yang Y; You Y; Liu Y; Geng L; Huang L; Zhou H; Piao X; Liu X; Wu M; Wang Y; Zhou L; Wang P; Shen S; Hu M; Han Z; Xue Z
BMC Infect Dis; 2023 Apr; 23(1):264. PubMed ID: 37101288
[TBL] [Abstract][Full Text] [Related]
14. Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines.
Ye ZW; Fan Y; Tang K; Ong CP; Luo C; Chung HL; Leong TL; Liang R; Lui WY; Zhou R; Cheng Y; Lu L; Cheung PH; Chan JF; Chen Z; Yuen KY; Yuan S; To KK; Jin DY
Int J Biol Sci; 2022; 18(12):4781-4791. PubMed ID: 35874942
[TBL] [Abstract][Full Text] [Related]
15. Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant.
Yu X; Qi X; Cao Y; Li P; Lu L; Wang P; Feng Y; Yang J; Wei H; Guo L; Sun M; Liu Q; Lv J; Feng Y
Emerg Microbes Infect; 2022 Dec; 11(1):749-752. PubMed ID: 35176972
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinical characteristics of patients with different vaccines and underlying diseases infected with novel coronavirus Omicron variant].
Xu H; Wang J; Gao H; Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):571-575. PubMed ID: 35924509
[TBL] [Abstract][Full Text] [Related]
17. The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.
Zou Y; Huang D; Jiang Q; Guo Y; Chen C
Front Public Health; 2022; 10():940956. PubMed ID: 35910897
[TBL] [Abstract][Full Text] [Related]
18. T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.
Atanackovic D; Kreitman RJ; Cohen J; Hardy NM; Omili D; Iraguha T; Burbelo PD; Gebru E; Fan X; Baddley J; Luetkens T; Dahiya S; Rapoport AP
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35851312
[TBL] [Abstract][Full Text] [Related]
19. Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera.
Zhou W; He P; Li J; Liu H; Shi M; Yu J; Wei H
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215927
[TBL] [Abstract][Full Text] [Related]
20. Exploring the clinical application value of peripheral blood T lymphocyte subset in patients with asymptomatic omicron infection.
Li T; Xu J; Gao Y; Wang X; Xu Y
Eur J Med Res; 2023 Jul; 28(1):223. PubMed ID: 37408049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
